Taken together, these results suggest that Grem2-overexpressing adipocytes have the potential to suppress the expression of cytokines, including IL-6, in adipocytes or breast cancer cells, which may contribute to the inhibition of breast cancer progression. Here, GREM2 is linked to breast cancer.